Getinge (OTCMKTS:GNGBY) Releases Earnings Results

Getinge (OTCMKTS:GNGBY) released its earnings results on Friday. The company reported $0.38 earnings per share (EPS) for the quarter, Zacks reports. Getinge had a return on equity of 10.39% and a net margin of 6.92%.

Getinge Stock Performance

GNGBY opened at $21.70 on Friday. The company has a quick ratio of 0.86, a current ratio of 1.32 and a debt-to-equity ratio of 0.27. Getinge has a 12-month low of $18.99 and a 12-month high of $24.67. The business has a 50 day moving average of $20.57 and a 200-day moving average of $21.32. The stock has a market cap of $5.91 billion, a price-to-earnings ratio of 23.59 and a beta of 0.96.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded Getinge to a “hold” rating in a research note on Thursday, April 23rd. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, Getinge presently has a consensus rating of “Moderate Buy”.

About Getinge

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.